JNJ
JOHNSON & JOHNSON
NYSE · Healthcare · Drug Manufacturers - General · US
$269.99
−0.09%Forward multiples
Based on analyst estimates
- P/E forward
- 22.69x
- P/E 2026E
- 23.37x
- P/E 2027E
- 21.16x
- P/E 2028E
- 18.84x
- P/S forward
- 6.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- 31.21x
- PEG TTM
- 0.83x
- Price / book
- 7.66x
- Price / sales
- 6.64x
- Price / cash flow
- 27.45x
Enterprise value
- Enterprise value
- $678.9B
- EV / sales
- 6.93x
- EV / EBITDA
- 20.13x
- EV / EBIT
- 25.86x
- Market cap
- $650.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026